Vascular and Myocardial Function in Young People with Type 1 Diabetes Mellitus: Insulin Pump Therapy Versus Multiple Daily Injections Insulin Regimen

Abstract

Introduction Multiple daily injections (MDI) and continuous subcutaneous insulin infusion (CSII) are two modalities of treating type 1 diabetes mellitus (T1DM). The benefits of CSII on long-term metabolic control and outcomes compared to those of MDI are still debated. We investigated both vascular function and myocardial performance in T1DM adolescents on MDI or CSII treatment.

Methods One hundred twenty-three T1DM subjects (mean age 14.16±2.55 years), 63 on MDI regimen, 60 on CSII, and 57 controls were enrolled. Anthropometric and biochemical characteristics were evaluated. Ultrasound assessments of carotid intima-media thickness (cIMT), flow-mediated dilatation of brachial artery, anteroposterior diameter of the infrarenal abdominal aorta (APAO), and transthoracic echocardiography were performed.

Results T1DM subjects on the CSII regimen showed better glycemic control than those on MDI, expressed as glycated haemoglobin (HbA1c). c-IMT and APAO were higher in MDI than CSII patients (0.61±0.11 mm vs. 0.56±0.07 mm, p=0.04; 13.61±3.29 mm vs. 11.65±1.84 mm, p=0.01, respectively). Left and right Tei index and left E/e’ ratio were higher in MDI than CSII subjects (0.82±0.40 vs. 0.52±0.19, p=0.002; 0.86±0.41 vs. 0.64±0.1, p=0.02; 5.89±2.0 vs. 4.73±1.59, p=0.02, respectively). Multiple regression analyses showed that glucose level, HbA1c and diabetes onset were significantly related to vascular and echocardiographic parameters in MDI and CSII patients.

Conclusions CSII regimen in T1DM adolescents improves glycemic control and seems to ameliorate endothelial function and global myocardial performance as compared to MDI therapy.

Key words

type 1 diabetes - CSII - MDI - endothelial function - myocardial performance

Publication History

Received: 25 February 2021
Received: 30 April 2021

Accepted: 28 May 2021

Article published online:
12 August 2021

• References

• 1 Mayer-Davis EJ, Kahkoska AR, Jefferies C. et al. ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 2018; 19: 7-19
• 2 Bjornstad P, Donaghue KC, Maahs DM. Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?. Lancet Diabetes Endocrinol 2018; 6: 809-820
• 3 Rawshani A, Sattar N, Franzén S. et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018; 392: 477-486
• 4 Cameron FJ, Wherrett DK. Care of diabetes in children and adolescents: controversies, changes, and consensus. Lancet 2015; 385: 2096-2106
• 5 Nadeau KJ, Regensteiner JG, Bauer TA. et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab 2010; 95: 513-521
• 6 Diabetes Control and Complications Trial Research Group. Nathan DM, Genuth S. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
• 7 Subramanian S, Hirsch IB. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes mellitus: Implications of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study 30-year follow-up. Endocrinol Metab Clin North Am 2018; 47: 65-79
• 8 DiMeglio LA, Acerini CL, Codner E. et al. ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 2018; 19: 105-114
• 9 American Diabetes Association. 13. Children and Adolescents: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019; 42: S148-S164
• 10 Prahalad P, Tanenbaum M, Hood K. et al. Diabetes technology: improving care, improving patient-reported outcomes and preventing complications in young people with Type 1 diabetes. Diabet Med 2018; 35: 419-429
• 11 Alemzadeh R, Palma-Sisto P, Holzum M. et al. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Diabetes Technol Ther 2007; 9: 339-347
• 12 Pickup JC, Kidd J, Burmiston S. et al. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006; 22: 232-237
• 13 Hirsch IB. Glycemic variability and diabetes complications: Does it matter? Of course it does!. Diabetes Care 2015; 38: 1610-1614
• 14 Bekiari E, Kitsios K, Thabit H. et al. Artificial pancreas treatment for outpatients with type 1 diabetes: Systematic review and meta-analysis. Brit Med J 2018; 361: k1310
• 15 Fatourechi MM, Kudva YC, Murad MH. et al. Clinical review: Hypoglycemia with intensive insulin therapy: A systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009; 94: 729-740
• 16 Mameli C, Scaramuzza AE, Ho J. et al. A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes. Acta Diabetol 2014; 51: 205-210
• 17 Faienza MF, Ventura A, Delvecchio M. et al. High sclerostin and dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus. J Clin Endocrinol Metab 2017; 102: 1174-1181
• 18 Karges B, Schwandt A, Heidtmann B. et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA 2017; 318: 1358-1366
• 19 Rasmussen VF, Vestergaard ET, Schwandt A. et al. Proportion of basal to total insulin dose is associated with metabolic control, body mass index, and treatment modality in children with type 1 diabetes-A cross-sectional study with data from the International SWEET registry. J Pediatr 2019; 215: 216-222
• 20 Colaianni G, Faienza MF, Sanesi L. et al. Irisin serum levels are positively correlated with bone mineral status in a population of healthy children. Pediatr Res 2019; 85: 484-488
• 21 Faienza MF, Brunetti G, Sanesi L. et al. High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes. Diabetes Res Clin Pract 2018; 141: 10-17
• 22 Harrington J, Peña AS, Wilson L. et al. Vascular function and glucose variability improve transiently following initiation of continuous subcutaneous insulin infusion in children with type 1 diabetes. Pediatr Diabetes 2013; 14: 504-511
• 23 Ersoy B, Eroğlu N, Çetin M. et al. Asymmetric dimethylarginine levels and diabetes duration: relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes. Diab Vasc Dis Res 2018; 15: 196-203
• 24 Ogden CL, Flegal KM, Carroll MD. et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-1732
• 25 Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170-179
• 26 Flynn JT, Kaelber DC, Baker-Smith CM. et al. Subcomittee on screening and management of high blood pressure in children. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 2017; 140: e20171904
• 27 Faienza MF, Brunetti G, Delvecchio M. et al. Vascular function and myocardial performance indices in children born small for gestational age. Circ J 2016; 80: 958-963
• 28 Touboul PJ, Hennerici MG, Meairs S. et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis 2012; 34: 290-296
• 29 Miniello VL, Faienza MF, Scicchitano P. et al. Insulin resistance and endothelial function in children and adolescents. Int J Cardiol 2014; 174: 343-347
• 30 Corretti MC, Anderson TJ, Benjamin EJ. et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265
• 31 Lopez L, Colan SD, Frommelt PC. et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010; 23: 465-495
• 32 Ciccone MM, Faienza MF, Altomare M. et al. Endothelial and metabolic function interactions in overweight/obese children. J Atheroscler Thromb 2016; 23: 950-959
• 33 Giordano P, Muggeo P, Delvecchio M. et al. Endothelial dysfunction and cardiovascular risk factors in childhood acute lymphoblastic leukemia survivors. Int J Cardiol 2017; 228: 621-627
• 34 Delvecchio M, Muggeo P, Monteduro M. et al. Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. Eur J Endocrinol 2017; 176: 111-121
• 35 Faienza MF, Acquafredda A, Tesse R. et al. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int J Med Sci 2013; 10: 338-343
• 36 Sun J, Xu Y, Dai Z. et al. Intermittent high glucose enhances proliferation of vascular smooth muscle cells by upregulating osteopontin. Mol Cell Endocrinol 2009; 313: 64-69
• 37 Ceriello A, Novials A, Ortega E. et al. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes 2012; 61: 2993-2997
• 38 Piconi L, Quagliaro L, Assaloni R. et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 2006; 22: 198-203
• 39 Faienza MF, Francavilla R, Goffredo R. et al. Oxidative stress in obesity and metabolic syndrome in children and adolescents. Horm Res Paediatr 2012; 78: 158-164
• 40 Głowińska-Olszewska B, Moniuszko M, Hryniewicz A. et al. Relationship between circulating endothelial progenitor cells and endothelial dysfunction in children with type 1 diabetes: A novel paradigm of early atherosclerosis in high-risk young patients. Eur J Endocrinol 2013; 168: 153-161
• 41 Nascimento AMMAD, Sequeira IJ, Vasconcelos DF. et al. Endothelial dysfunction in children with type 1 diabetes mellitus. Arch Endocrinol Metab 2017; 61: 476-483
• 42 Phelan H, Clapin H, Bruns L. et al. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes. Med J Aust 2017; 206: 121-125
• 43 Miller KM, Foster NC, Beck RW. et al. T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015; 38: 971-978
• 44 Järvisalo MJ, Raitakari M, Toikka JO. et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109: 1750-1755
• 45 Tołwińska J, Głowińska-Olszewska B, Bossowski A. Insulin therapy with personal insulin pumps and early angiopathy in children with type 1 diabetes mellitus. Mediators Inflamm 2013; 2013: 791283
• 46 Dalla Pozza R, Netz H, Schwarz HP. et al. Subclinical atherosclerosis in diabetic children: results of a longitudinal study. Pediatr Diabetes 2010; 11: 129-133
• 47 Bruttomesso D, Crazzolara D, Maran A. et al. In type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008; 25: 326-332
• 48 Rosenlund S, Theilade S, Hansen TW. et al. Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness. Acta Diabetol 2014; 51: 955-962
• 49 Hensel KO, Grimmer F, Roskopf M. et al. Subclinical alterations of cardiac mechanics present early in the course of pediatric type 1 diabetes mellitus: A prospective blinded speckle tracking stress echocardiography study. J Diabetes Res 2016; 2016: 2583747
• 50 Chahal NS, Lim TK, Jain P. et al. The distinct relationships of carotid plaque disease and carotid intima-media thickness with left ventricular function. J Am Soc Echocardiogr 2010; 23: 1303-1309
• 51 Sharma RK, Donekal S, Rosen BD. et al. Association of subclinical atherosclerosis using carotid intima-media thickness, carotid plaque, and coronary calcium score with left ventricular dyssynchrony: the multi-ethnic Study of Atherosclerosis. Atherosclerosis 2015; 239: 412-418
• 52 Yoldaş T, Örün UA, Sagsak E. et al. Subclinical left ventricular systolic and diastolic dysfunction in type 1 diabetic children and adolescents with good metabolic control. Echocardiography 2018; 35: 227-233
• 53 M Abd-El Aziz F, Abdelghaffar S, M Hussien E et al. Evaluation of cardiac functions in children and adolescents with type 1 diabetes. J Cardiovasc Ultrasound 2017; 25: 12-19
• 54 Ozdemir O, Koksoy AY, Bulus AD. et al. The effects of type 1 diabetes mellitus on cardiac functions in children: Evaluation by conventional and tissue Doppler echocardiography. J Pediatr Endocrinol Metab 2016; 29: 1389-1395